RE: CoTec Holdings Corp. Announces Life Offering and Concurrent Private Placement20 May 2025 15:58
I've seen Julian talk about this topic in one of his investor Q&A sessions, though he wasn't particularly clear, and I haven't seen any details written down anywhere. I've made some assumptions myself around how it may work, but would be good to have this confirmed by the company in due course. One thing is clear, we don't need to raise any money at Mkango in order to keep our c.40% stake (through 79.4% Maginito stake), so no fundraising needed on our side.
I assume that any grant funding just directly reduces the financing requirement and the benefit of this is therefore shared between Cotec and Mkango. Any devex costs (such as the FEED study) that Cotec have funded themselves will need to be repaid, as is completely normal before equity starts getting paid out. Any debt financing will be senior to equity holders, and debt service will need to be covered before distributions to equity are made.
Beyond that, I am not clear on how distributions will be structured between Mkango and Cotec, or more accurately between Maginitio and Cotec (noting Cotec also own 20.6% of Maginito). I am pretty certain though, that we can't be diluted from our c.40% position in Hypromag USA. It may be that any cash equity that Cotec put into financing the project is structured as subordinated debt (a form of shareholder investment used in project finance), which is serviced before wider equity distributions (dividends) are paid to the parent(s) i.e. Cotec and Maginito.